300439 美康生物
按盤價 
10.020 +0.440 (+4.593%)
10.020 +0.440 (+4.593%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.424 | 9.820 | 8.175 | 9.000 | 20.110 |
| 總資產報酬率 ROA (%) | 5.099 | 7.255 | 5.532 | 5.243 | 8.563 |
| 投入資產回報率 ROIC (%) | 5.960 | 8.631 | 6.675 | 6.350 | 11.782 | 邊際利潤分析 |
| 銷售毛利率 (%) | 46.484 | 44.604 | 38.151 | 40.475 | 36.850 |
| 營業利潤率 (%) | 19.720 | 14.800 | 9.186 | 9.758 | 7.512 |
| 息稅前利潤/營業總收入 (%) | 19.998 | 15.588 | 9.165 | 10.852 | 17.398 |
| 淨利潤/營業總收入 (%) | 18.788 | 13.760 | 8.244 | 8.445 | 12.753 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 85.163 | 75.904 | 126.522 | 109.508 | 53.120 |
| 價值變動淨收益/利潤總額(%) | 4.492 | 5.049 | 1.736 | -1.249 | 4.913 |
| 營業外收支淨額/利潤總額(%) | 3.874 | 5.601 | -2.389 | -0.672 | 50.174 | 償債能力分析 |
| 流動比率 (X) | 3.048 | 2.716 | 2.111 | 1.894 | 1.130 |
| 速動比率 (X) | 2.630 | 2.346 | 1.889 | 1.695 | 0.947 |
| 資產負債率 (%) | 19.357 | 22.426 | 29.697 | 33.465 | 48.159 |
| 帶息債務/全部投入資本 (%) | 3.342 | 5.503 | 13.332 | 17.591 | -- |
| 股東權益/帶息債務 (%) | 2,808.308 | 1,666.151 | 630.987 | 450.029 | 169.960 |
| 股東權益/負債合計 (%) | 418.074 | 346.959 | 235.857 | 195.186 | 104.754 |
| 利息保障倍數 (X) | -38.708 | -170.993 | 47.245 | 9.365 | 7.492 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 108.990 | 132.059 | 117.634 | 133.259 | 0.000 |
| 存貨周轉天數 (天) | 89.986 | 82.195 | 50.210 | 62.494 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
